Literature DB >> 30332981

Deregulation of miR-21 and miR-29a in Cervical Cancer Related to HPV Infection.

Sara Zamani1, Amir Sohrabi2,3, Seyed Masoud Hosseini1, Marjan Rahnamaye-Farzami4, Abolfazl Akbari5.   

Abstract

BACKGROUND: Early diagnosis is an important factor to improve the survival of Invasive Cervical Cancer (ICC) patients. Molecular biomarkers such as micro RNA (miRNA) can be used in the early detection of ICC. The expression of miR-21 and miR-29a are deregulated in many types of human cancers.
OBJECTIVE: The aim of this study was to investigate the differences in miR-21 and miR-29a expression patterns in the Human Papilloma Virus (HPV) infection and various grades of cervical cancer among Iranian women.
METHODS: Small RNAs were extracted from positive for HPV, cervical cancer and healthy samples from 43, 50 and 46 individuals, respectively. Expression levels of miR-21 and miR-29a were analyzed by SYBR Green real-time RT-PCR using specific primers, and 5s rRNA as the internal reference gene.
RESULTS: Results have shown a significant increase in miR-21 and decrease in miR-29 in cancerous samples in comparison with the control groups (P < 0.0001).
CONCLUSION: This study illustrated that miR-21 and miR-29a could be operated as an oncogene and tumor-suppressor in cervical cancer progression. More studies are needed to demonstrate the role of miR-21 and miR-29a as potential biomarkers for the diagnosis of cervical cancer in future investigations. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Biomarker; HPV; cervical cancer; infection; miR-21; miR-29a; microRNA.

Mesh:

Substances:

Year:  2019        PMID: 30332981     DOI: 10.2174/2211536607666181017124349

Source DB:  PubMed          Journal:  Microrna


  13 in total

Review 1.  The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.

Authors:  Pui-Wah Choi; Tin Lun Liu; Chun Wai Wong; Sze Kei Liu; Yick-Liang Lum; Wai-Kit Ming
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 2.  microRNA-21: a key modulator in oncogenic viral infections.

Authors:  Guitian He; Juntao Ding; Yong'e Zhang; Mengting Cai; Jing Yang; William C Cho; Yadong Zheng
Journal:  RNA Biol       Date:  2021-03-22       Impact factor: 4.652

3.  Integrated analysis of circular RNA-associated ceRNA network in cervical cancer: Observational Study.

Authors:  Jun Gong; Hui Jiang; Chang Shu; Mei-Qin Hu; Yan Huang; Qin Liu; Rong-Feng Li; Yin-Zhi Wei
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis.

Authors:  Ping Nan; Yugui Niu; Xiuhua Wang; Qiang Li
Journal:  Onco Targets Ther       Date:  2019-08-26       Impact factor: 4.147

5.  Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.

Authors:  Aiping Dong; Bin Xu; Zhanzhao Wang; Xia Miao
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

6.  MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1.

Authors:  Xiurong Lu; Xiao Song; Xiaohui Hao; Xiaoyu Liu; Xianyu Zhang; Na Yuan; Huan Ma; Zhilin Zhang
Journal:  World J Surg Oncol       Date:  2021-07-12       Impact factor: 2.754

Review 7.  Human papilloma virus: A review study of epidemiology, carcinogenesis, diagnostic methods, and treatment of all HPV-related cancers.

Authors:  Maryam Soheili; Hossein Keyvani; Marzieh Soheili; Sherko Nasseri
Journal:  Med J Islam Repub Iran       Date:  2021-05-22

Review 8.  The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review).

Authors:  Martha Laysla Ramos Da Silva; Beatriz Helena Dantas Rodrigues De Albuquerque; Thales Araújo De Medeiros Fernandes Allyrio; Valéria Duarte De Almeida; Ricardo Ney De Oliveira Cobucci; Fabiana Lima Bezerra; Vania Sousa Andrade; Daniel Carlos Ferreira Lanza; Jenner Christian Veríssimo De Azevedo; Josélio Maria Galvão De Araújo; José Veríssimo Fernandes
Journal:  Biomed Rep       Date:  2021-05-20

9.  Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis.

Authors:  Tingting Sun; Jing Chen; Xuechao Sun; Guonian Wang
Journal:  Cancer Cell Int       Date:  2021-07-28       Impact factor: 5.722

Review 10.  Cervical Cancer, Papillomavirus, and miRNA Dysfunction.

Authors:  Evelyn Gabriela Bañuelos-Villegas; María Fernanda Pérez-yPérez; Luis Marat Alvarez-Salas
Journal:  Front Mol Biosci       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.